Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecule is a decentralized science (DeSci) platform that transforms the way biopharmaceutical intellectual property is funded and managed. The company utilizes blockchain technology to create IP-NFTs (Intellectual Property Non-Fungible Tokens), enabling researchers to tokenize their work and connect directly with decentralized autonomous organizations (DAOs) and patient communities. By providing a marketplace for early-stage drug discovery assets, Molecule aims to democratize access to biotech investment and accelerate the development of novel therapeutics. The platform currently supports several specialized communities, including VitaDAO for longevity and AthenaDAO for women's health, fostering a collaborative ecosystem for scientific advancement. Molecule's infrastructure allows for fractional ownership and transparent governance of research projects, bridging the gap between academia and industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecule.